Gilead Sciences News - August 3, 2026

Gilead wins HIV drug lawsuit, court rejects duty to innovate rule

The California Supreme Court ruled in favor of Gilead Sciences, finding the company had no legal obligation to release newer HIV treatments sooner....

Gilead Sciences Inc Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026

Gilead Sciences is expected to report Q2 2026 revenue of $7.40 billion and a consensus loss of $7.07 per share, with the stock currently trading at $130.26...